Colgate-Palmolive is rated Buy due to strong execution, margin expansion, and a valuation below its historical average. Growth is driven by its Hill's Pet Nutrition division, which benefits from premium product innovation and expansion into fresh pet food. The company is also accelerating organic sales through premium innovation, increased advertising, and exposure to emerging markets. Cost-saving initiatives help offset inflation and improve margins, supporting long-term growth prospects.
As of Nov 04, 2026 17:01 WIB, Colgate-Palmolive shares trade at USD 95.73 on Pluang, showing a modest 0.12% increase in the past day. The stock enjoys full buy interest from Pluang users, with no sell orders recorded. Its market capitalization stands at $77.45 billion, highlighting its significant presence in the consumer staples sector.
Colgate-Palmolive reported a solid third quarter with revenues growing 3.6% organically, driven by strong momentum in international markets. The company's profitability improved due to higher sales of premium products and increased marketing investme...
Colgate-Palmolive reported Q3 earnings and sales slightly above market estimates, with a notable strength in gross margin, which remains the key growth driver. The company showed positive signs in important segments, supporting a favorable outlook fo...
